Lagnason, Quinn Ryzle R.
HRN: 21-39-75 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2025
CEFUROXIME 750MG (VIAL)
08/25/2025
08/31/2025
IV
550mg
Q8h
UTI
Checking Initial Appropriateness